Cargando…

Localization of the Epileptogenic Zone Using High Frequency Oscillations

For patients with drug-resistant focal epilepsy, surgery is the therapy of choice in order to achieve seizure freedom. Epilepsy surgery foremost requires the identification of the epileptogenic zone (EZ), defined as the brain area indispensable for seizure generation. The current gold standard for i...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomschewski, Aljoscha, Hincapié, Ana-Sofía, Frauscher, Birgit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378911/
https://www.ncbi.nlm.nih.gov/pubmed/30804887
http://dx.doi.org/10.3389/fneur.2019.00094
_version_ 1783396014852407296
author Thomschewski, Aljoscha
Hincapié, Ana-Sofía
Frauscher, Birgit
author_facet Thomschewski, Aljoscha
Hincapié, Ana-Sofía
Frauscher, Birgit
author_sort Thomschewski, Aljoscha
collection PubMed
description For patients with drug-resistant focal epilepsy, surgery is the therapy of choice in order to achieve seizure freedom. Epilepsy surgery foremost requires the identification of the epileptogenic zone (EZ), defined as the brain area indispensable for seizure generation. The current gold standard for identification of the EZ is the seizure-onset zone (SOZ). The fact, however that surgical outcomes are unfavorable in 40–50% of well-selected patients, suggests that the SOZ is a suboptimal biomarker of the EZ, and that new biomarkers resulting in better postsurgical outcomes are needed. Research of recent years suggested that high-frequency oscillations (HFOs) are a promising biomarker of the EZ, with a potential to improve surgical success in patients with drug-resistant epilepsy without the need to record seizures. Nonetheless, in order to establish HFOs as a clinical biomarker, the following issues need to be addressed. First, evidence on HFOs as a clinically relevant biomarker stems predominantly from retrospective assessments with visual marking, leading to problems of reproducibility and reliability. Prospective assessments of the use of HFOs for surgery planning using automatic detection of HFOs are needed in order to determine their clinical value. Second, disentangling physiologic from pathologic HFOs is still an unsolved issue. Considering the appearance and the topographic location of presumed physiologic HFOs could be immanent for the interpretation of HFO findings in a clinical context. Third, recording HFOs non-invasively via scalp electroencephalography (EEG) and magnetoencephalography (MEG) is highly desirable, as it would provide us with the possibility to translate the use of HFOs to the scalp in a large number of patients. This article reviews the literature regarding these three issues. The first part of the article focuses on the clinical value of invasively recorded HFOs in localizing the EZ, the detection of HFOs, as well as their separation from physiologic HFOs. The second part of the article focuses on the current state of the literature regarding non-invasively recorded HFOs with emphasis on findings and technical considerations regarding their localization.
format Online
Article
Text
id pubmed-6378911
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63789112019-02-25 Localization of the Epileptogenic Zone Using High Frequency Oscillations Thomschewski, Aljoscha Hincapié, Ana-Sofía Frauscher, Birgit Front Neurol Neurology For patients with drug-resistant focal epilepsy, surgery is the therapy of choice in order to achieve seizure freedom. Epilepsy surgery foremost requires the identification of the epileptogenic zone (EZ), defined as the brain area indispensable for seizure generation. The current gold standard for identification of the EZ is the seizure-onset zone (SOZ). The fact, however that surgical outcomes are unfavorable in 40–50% of well-selected patients, suggests that the SOZ is a suboptimal biomarker of the EZ, and that new biomarkers resulting in better postsurgical outcomes are needed. Research of recent years suggested that high-frequency oscillations (HFOs) are a promising biomarker of the EZ, with a potential to improve surgical success in patients with drug-resistant epilepsy without the need to record seizures. Nonetheless, in order to establish HFOs as a clinical biomarker, the following issues need to be addressed. First, evidence on HFOs as a clinically relevant biomarker stems predominantly from retrospective assessments with visual marking, leading to problems of reproducibility and reliability. Prospective assessments of the use of HFOs for surgery planning using automatic detection of HFOs are needed in order to determine their clinical value. Second, disentangling physiologic from pathologic HFOs is still an unsolved issue. Considering the appearance and the topographic location of presumed physiologic HFOs could be immanent for the interpretation of HFO findings in a clinical context. Third, recording HFOs non-invasively via scalp electroencephalography (EEG) and magnetoencephalography (MEG) is highly desirable, as it would provide us with the possibility to translate the use of HFOs to the scalp in a large number of patients. This article reviews the literature regarding these three issues. The first part of the article focuses on the clinical value of invasively recorded HFOs in localizing the EZ, the detection of HFOs, as well as their separation from physiologic HFOs. The second part of the article focuses on the current state of the literature regarding non-invasively recorded HFOs with emphasis on findings and technical considerations regarding their localization. Frontiers Media S.A. 2019-02-12 /pmc/articles/PMC6378911/ /pubmed/30804887 http://dx.doi.org/10.3389/fneur.2019.00094 Text en Copyright © 2019 Thomschewski, Hincapié and Frauscher. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Thomschewski, Aljoscha
Hincapié, Ana-Sofía
Frauscher, Birgit
Localization of the Epileptogenic Zone Using High Frequency Oscillations
title Localization of the Epileptogenic Zone Using High Frequency Oscillations
title_full Localization of the Epileptogenic Zone Using High Frequency Oscillations
title_fullStr Localization of the Epileptogenic Zone Using High Frequency Oscillations
title_full_unstemmed Localization of the Epileptogenic Zone Using High Frequency Oscillations
title_short Localization of the Epileptogenic Zone Using High Frequency Oscillations
title_sort localization of the epileptogenic zone using high frequency oscillations
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378911/
https://www.ncbi.nlm.nih.gov/pubmed/30804887
http://dx.doi.org/10.3389/fneur.2019.00094
work_keys_str_mv AT thomschewskialjoscha localizationoftheepileptogeniczoneusinghighfrequencyoscillations
AT hincapieanasofia localizationoftheepileptogeniczoneusinghighfrequencyoscillations
AT frauscherbirgit localizationoftheepileptogeniczoneusinghighfrequencyoscillations